US-based patient management software developer CareSync raised $18m in a series B round yesterday that included pharmaceutical company Merck’s Global Health Innovation Fund.
The series B consortium also featured Greycroft Partners, Harbert Venture Partners, Tullis Health Investors, Clearwell Group, CDH Solutions and Travis Bond, the founder and chief executive of CareSync.
Founded in 2011, CareSync has built a turnkey chronic disease management platform that captures, organises and shares relevant health data with patients, family, caregivers and healthcare professionals.
The series B cash will go towards further product development and the recruitment of an additional 500 staff over the next 18 months.
CareSync previously secured $4.3m in series A funding in October 2014 from Tullis, Clearwell, CDH and Travis Bond.